{"id":"NCT01757405","sponsor":"Baxalta now part of Shire","briefTitle":"Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen","officialTitle":"A PHASE 3, PROSPECTIVE, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE SAFETY AND EFFICACY OF RECOMBINANT ACTIVATED FVII BI (rFVIIa BI) IN THE TREATMENT OF ACUTE BLEEDING EPISODES PER AN ON-DEMAND REGIMEN IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02-20","primaryCompletion":"2014-11-11","completion":"2014-11-11","firstPosted":"2012-12-28","resultsPosted":"2016-10-25","lastUpdate":"2021-05-11"},"enrollment":40,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia A","Hemophilia B"],"interventions":[{"type":"BIOLOGICAL","name":"Recombinant Factor VIIa BI (rFVIIa BI)","otherNames":[]},{"type":"BIOLOGICAL","name":"Recombinant Factor VIIa BI (rFVIIa BI)","otherNames":[]}],"arms":[{"label":"≤ 3 doses of 90 µg/kg rFVIIa BI","type":"EXPERIMENTAL"},{"label":"One dose of 270 µg/kg rFVIIa BI","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to determine the efficacy and safety of rFVIIa BI as part of a six-month on-demand treatment regimen in hemophilia A or B subjects with inhibitors.","primaryOutcome":{"measure":"Percentage of Bleeding Episode With \"Treatment Success\"","timeFrame":"within 12 hours of first dose","effectByArm":[{"arm":"Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI","deltaMin":96.19,"sd":null},{"arm":"Arm 2: 1 x 270 Micrograms/kg rFVIIa BI","deltaMin":79.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":11},"locations":{"siteCount":16,"countries":["United States","Japan","Poland","Romania","Russia","Serbia","Spain","Taiwan","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":18},"commonTop":["Influenza","Laceration","Hepatic Enzyme Increased","Nasal Congestion","Oropharyngeal Pain"]}}